The ACUSON S2000™ cardiovascular (CV) ultrasound system offers premium image quality and highest clinical performance for a wide variety of cardiovascular patients.
Knowledge-based applications automate measurements and individually customizable protocols streamline clinical workflow for rapid, accurate and reproducible results. The system’s open architecture and transducer compatibility across multiple Siemens ultrasound platforms protect investment and offer an entirely new price/performance level.
The ACUSON S2000 CV system is built on next-generation acoustic technologies that enable you to experience never-before-seen detail during examinations. Optimized for high-frequency imaging, the ACUSON S2000 CV system delivers superb 2D, Color, Pulsed and Continuous Wave Doppler to provide you unprecedented levels of diagnostic confidence for the best possible outcomes.
The ACUSON S2000 software applications are developed using “machine learning.” The software uses advanced algorithms and an expert database of real clinical cases to recognize anatomical patterns and landmarks as well as perform automatic measurements. This knowledge-based approach expedites workflow and helps keep you on schedule. New eSieScan™ workflow protocols significantly reduce exam time and system interaction for increased patient throughput.
The ACUSON S2000 CV system takes Home Base to a whole new level by putting everything within easy reach. Whether sitting or standing, you’ll experience the unprecedented ease and comfort of simple, stress-free operation. Compact and lightweight, the ACUSON S2000 CV system is highly portable, user-friendly and versatile enough to accommodate a wide range of exams and environments.
The ACUSON S2000 CV system greatly extends your diagnostic reach. It addresses a broad range of today’s most cutting-edge clinical applications.
Protect your investment and bring an entirely new price/performance level to your imaging needs through Siemens’ open architecture approach and transducer compatibility across multiple ACUSON ultrasound platforms.
* At the time of publication, the U.S. Food & Drug Administration has cleared ultrasound contrast agents only for use in LVO. Check the current regulation for the country in which you are using this system for contrast agent clearance.
** This feature should be utilized according to the ASE Consensus Statement "Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Medicine”